Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013 (2013), Article ID 628513, 7 pages
http://dx.doi.org/10.1155/2013/628513
Case Report

An Acquired Factor VIII Inhibitor in a Patient with HIV and HCV: A Case Presentation and Literature Review

1Department of Internal Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA
2Department of Radiology, Mount Sinai Medical Center, Miami Beach, FL 33140, USA
3Division of Hematology/Oncology, Mount Sinai Medical Center, Miami Beach, FL 33140, USA

Received 26 July 2013; Accepted 29 August 2013

Academic Editors: R. Herrmann, K. Khair, M.-C. Kyrtsonis, and Y. Matsukawa

Copyright © 2013 S. B. Zeichner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Collins, N. Macartney, R. Davies, S. Lees, J. Giddings, and R. Majer, “A population based, unselected, consecutive cohort of patie with acquired haemophilia A,” British Journal of Haematology, vol. 124, no. 1, pp. 86–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. P. W. Collins, S. Hirsch, T. P. Baglin et al., “Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' organisation,” Blood, vol. 109, no. 5, pp. 1870–1877, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Green and K. Lechner, “A survey of 215 non-hemophilic patients with inhibitors to factor VIII,” Thrombosis and Haemostasis, vol. 45, no. 3, pp. 200–203, 1981. View at Google Scholar · View at Scopus
  4. I. Hauser, B. Schneider, and K. Lechner, “Post-partum factor VIII inhibitors: a review of the literature with special reference to the value of steroid and immunosuppressive treatment,” Thrombosis and Haemostasis, vol. 73, no. 1, pp. 1–5, 1995. View at Google Scholar · View at Scopus
  5. M. Franchini, G. Gandini, T. Di Paolantonio, and G. Mariani, “Acquired hemophilia A: a concise review,” The American Journal of Hematology, vol. 80, no. 1, pp. 55–63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Knoebl, P. Marco, F. Baudo et al., “Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2),” Journal of Thrombosis and Haemostasis, vol. 10, no. 4, pp. 622–631, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Collins, F. Baudo, P. Knoebl et al., “Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2),” Blood, vol. 120, no. 1, pp. 47–55, 2012. View at Google Scholar
  8. D. Green, P. T. Schuette, and W. H. Wallace, “Factor VIII antibodies in rheumatoid arthritis. Effect of cyclophosphamide,” Archives of Internal Medicine, vol. 140, no. 9, pp. 1232–1235, 1980. View at Publisher · View at Google Scholar · View at Scopus
  9. R. M. G. Soriano, J. M. Matthews, and E. Guerado-Parra, “Acquired haemophilia and rheumatoid arthritis,” British Journal of Rheumatology, vol. 26, no. 5, pp. 381–383, 1987. View at Google Scholar · View at Scopus
  10. T. E. Lafferty, J. B. Smith, S. J. Schuster, and R. J. DeHoratius, “Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 4, pp. 775–778, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. H. S. Ballard and G. Nyamuswa, “Life-threatening haemorrhage in a patient with rheumatoid arthritis and a lupus anticoagulant coexisting with acquired autoantibodies against factor VIII,” British Journal of Rheumatology, vol. 32, no. 3, pp. 515–517, 1993. View at Google Scholar · View at Scopus
  12. I. Hauser and K. Lechner, “Solid tumors and factor VIII antibodies,” Thrombosis and Haemostasis, vol. 82, no. 3, pp. 1005–1007, 1999. View at Google Scholar · View at Scopus
  13. C. W. Tiplady, P. J. Hamilton, and M. J. Galloway, “Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine,” Clinical and Laboratory Haematology, vol. 22, no. 3, pp. 163–165, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. K. E. English, W. F. Brien, K. Howson-Jan, and M. J. Kovacs, “Acquired factor VIII inhibitor in a patient with chronic myelogenous leukemia receiving interferon-alfa therapy,” Annals of Pharmacotherapy, vol. 34, no. 6, pp. 737–739, 2000. View at Google Scholar · View at Scopus
  15. A. Komminoth, P. Dufour, J. P. Bergerat, M. L. Wiesel, A. Falkenrodt, and F. Oberling, “Hairy cell leukemia and factor VIII inhibitor: a case report,” Nouvelle Revue Francaise d'Hematologie, vol. 34, no. 3, pp. 269–271, 1992. View at Google Scholar · View at Scopus
  16. P. Bossi, J. Cabane, J. Ninet et al., “Acquired hemophilia due to factor VIII inhibitors in 34 patients,” The American Journal of Medicine, vol. 105, no. 5, pp. 400–408, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. T. T. Yee, K. J. Pasi, P. A. Lilley, and C. A. Lee, “Factor VIII inhibitors in haemophiliacs: a single-centre experience over 34 years, 1964-97,” British Journal of Haematology, vol. 104, no. 4, pp. 909–914, 1999. View at Google Scholar · View at Scopus
  18. M. Franchini, “Postpartum acquired factor VIII inhibitors,” The American Journal of Hematology, vol. 81, no. 10, pp. 768–773, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Tengborn, F. Baudo, A. Huth-Kühne et al., “Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry,” BJOG, vol. 119, no. 12, pp. 1529–1537, 2012. View at Google Scholar
  20. J. Delyon, C. Mateus, and F. T. Lambert, “Hemophilia A induced by ipilimumab,” The New England Journal of Medicine, vol. 365, no. 18, pp. 1747–1748, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Sallah and J. Y. Wan, “Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine,” Thrombosis and Haemostasis, vol. 86, no. 4, pp. 1119–1121, 2001. View at Google Scholar · View at Scopus
  22. D. W. Sborov and G. M. Rodgers, “Acquired hemophilia A: a current review of autoantibody disease,” Clinical Advances in Hematology and Oncology, vol. 10, no. 1, pp. 19–27, 2012. View at Google Scholar · View at Scopus
  23. S. Paul, U. Javed, R. Tevendale, J. Lanford, and R. Liu, “Acquired factor VIII inhibitor in an HIV-infected patient after treatment with pegylated interferon-α 2a and ribavirin,” AIDS, vol. 21, no. 6, pp. 784–785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. A. Schreiber and N. Bräu, “Acquired factor VIII inhibitor in patients with hepatitis C virus infection and the role of interferon-α: a case report,” The American Journal of Hematology, vol. 80, no. 4, pp. 295–298, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Herman, L. Boggio, and D. Green, “Factor VIII inhibitor associated with peginterferon,” Haemophilia, vol. 11, no. 4, pp. 408–410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. E. C. Castenskiold, B. T. Colvin, and S. M. Kelsey, “Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy in a patient with haemophilia A,” British Journal of Haematology, vol. 87, no. 2, pp. 434–436, 1994. View at Google Scholar · View at Scopus
  27. N. Dentale, C. Fulgaro, L. Guerra, G. Fasulo, M. Mazzetti, and C. Fabbri, “Acquisition of factor VIII inhibitor after acute hepatitis C virus infection,” Blood, vol. 90, no. 8, pp. 3233–3234, 1997. View at Google Scholar · View at Scopus
  28. E. Migliore, A. Allione, L. Dutto et al., “Acquired factor VIII inhibitor in patient infected with HIV: a casual association or a prone immunological setting?” Haemophilia, vol. 15, no. 6, pp. 1334–1335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. F. Lake, S. F. Schluter, E. Wang, R. M. Bernstein, A. B. Edmundson, and J. J. Marchalonis, “Autoantibodies to the α/β T-cell receptors in human immunodeficiency virus infection: dysregulation and mimicry,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 23, pp. 10849–10853, 1994. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Gringeri, E. Santagostino, P. M. Mannucci et al., “A randomized, placebo-controlled, blind anti-AIDS clinical trial: safety and immunogenicity of a specific anti-IFNα immunization,” Journal of Acquired Immune Deficiency Syndromes, vol. 7, no. 9, pp. 978–988, 1994. View at Google Scholar · View at Scopus
  31. S. Indraccolo, M. Mion, R. Zamarchi et al., “B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets,” Journal of Clinical Immunology, vol. 13, no. 6, pp. 381–388, 1993. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Werwitzke, A. Tiede, M. Stoll, and M. von Depka, “Immune reconstitution inflammatory syndrome (IRIS) as a cause for inhibitor development in hemophilia,” Journal of Thrombosis and Haemostasis, vol. 2, no. 1, pp. 193–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Delgado, V. Jimenez-Yuste, F. Hernandez-Navarro, and A. Villar, “Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors,” British Journal of Haematology, vol. 121, no. 1, pp. 21–35, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Prescott, H. Nakai, E. L. Saenko et al., “The inhibitor antibody response is more complex in hemophilia a patients than in most nonhemophiliacs with factor VIII autoantibodies,” Blood, vol. 89, no. 10, pp. 3663–3671, 1997. View at Google Scholar · View at Scopus
  35. M. Arai, D. Scandella, and L. W. Hoyer, “Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chan prevent the interaction of factor VIII with phospholipid,” Journal of Clinical Investigation, vol. 83, no. 6, pp. 1978–1984, 1989. View at Google Scholar · View at Scopus
  36. D. Scandella, G. E. Gilbert, M. Shima et al., “Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site,” Blood, vol. 86, no. 5, pp. 1811–1819, 1995. View at Google Scholar · View at Scopus
  37. A. Mahendra, S. Padiolleau-Lefevre, S. V. Kaveri, and S. Lacroix-Desmazes, “Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?” British Journal of Haematology, vol. 156, no. 1, pp. 3–12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. C. R. M. Hay, S. Brown, P. W. Collins, D. M. Keeling, and R. Liesner, “The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation,” British Journal of Haematology, vol. 133, no. 6, pp. 591–605, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Vivaldi, G. Rossetti, M. Galli, and G. Finazzi, “Severe bleeeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature,” Haematologica, vol. 82, no. 3, pp. 345–347, 1997. View at Google Scholar · View at Scopus
  40. D. Erkan, H. Bateman, and M. D. Lockshin, “Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature,” Lupus, vol. 8, no. 7, pp. 560–564, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Hara, M. Makita, T. Ishikawa et al., “Lupus anticoagulant hypoprothrombinemia syndrome in Bence-Jones protein kappa-type multiple myeloma patient with phosphatidylserine-dependent antiprothrombin antibody,” Annals of Hematology, vol. 92, no. 4, pp. 563–564, 2013. View at Publisher · View at Google Scholar
  42. T. P. Giordano, L. Henderson, O. Landgren et al., “Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus,” Journal of the American Medical Association, vol. 297, no. 18, pp. 2010–2017, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. C. K. Kasper, L. Aledort, D. Aronson et al., “Proceedings: a more uniform measurement of factor VIII inhibitors,” Thrombosis et Diathesis Haemorrhagica, vol. 34, no. 2, article 612, 1975. View at Google Scholar
  44. P. W. Collins, “Treatment of acquired hemophilia A,” Journal of Thrombosis and Haemostasis, vol. 5, no. 5, pp. 893–900, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. P. W. Collins and C. L. Percy, “Advances in the understanding of acquired haemophilia A: implications for clinical practice,” British Journal of Haematology, vol. 148, no. 2, pp. 183–194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Franchini and G. Lippi, “Acquired factor VIII inhibitors,” Blood, vol. 112, no. 2, pp. 250–255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Sallah, “Treatment of acquired haemophilia with factor eight inhibitor bypassing activity,” Haemophilia, vol. 10, no. 2, pp. 169–173, 2004. View at Google Scholar · View at Scopus
  48. C. R. M. Hay, C. Negrier, and C. A. Ludlam, “The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study,” Thrombosis and Haemostasis, vol. 78, no. 6, pp. 1463–1467, 1997. View at Google Scholar · View at Scopus
  49. F. Baudo, P. Collins, A. Huth-Kühne et al., “Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry,” Blood, vol. 120, no. 1, pp. 39–46, 2012. View at Google Scholar
  50. P. W. Collins, “Management of acquired haemophilia A,” Journal of Thrombosis and Haemostasis, vol. 9, supplement 1, pp. 226–235, 2011. View at Google Scholar
  51. R. S. Schwartz, D. A. Gabriel, L. M. Aledort, D. Green, and C. M. Kessler, “A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin,” Blood, vol. 86, no. 2, pp. 797–804, 1995. View at Google Scholar · View at Scopus
  52. S. Schulman, P. Langevitz, A. Livneh, U. Martinowitz, U. Seligsohn, and D. Varon, “Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus,” Thrombosis and Haemostasis, vol. 76, no. 3, pp. 344–346, 1996. View at Google Scholar · View at Scopus
  53. A. G. Brox, H. Laryea, and M. Pelletier, “Successful treatment of acquired factor VIII inhibitors with cyclosporin,” The American Journal of Hematology, vol. 57, no. 1, pp. 87–88, 1998. View at Google Scholar
  54. P. S. Maclean, R. Campbell Tait, G. D. O. Lowe, I. D. Walker, and M. D. McColl, “Successful elimination of factor VIII inhibitor using cyclosporin A,” British Journal of Haematology, vol. 122, no. 6, pp. 1024–1025, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Petrovic, E. Derom, and G. Baele, “Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies,” Haematologica, vol. 85, no. 8, pp. 895–896, 2000. View at Google Scholar · View at Scopus
  56. S. Sallah and J. Y. Wan, “Efficacy of 2-chlorodeoxyadenosine in refractory factor VIII inhibitors in persons without hemophilia,” Blood, vol. 101, no. 3, pp. 943–945, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Jansen, S. Schmaldienst, S. Banyai et al., “Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb),” British Journal of Haematology, vol. 112, no. 1, pp. 91–97, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Freedman, M. L. Rand, O. Russell et al., “Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII,” Transfusion, vol. 43, no. 11, pp. 1508–1513, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Zeitler, G. Ulrich-Merzenich, L. Hess et al., “Treatment of acquired hemophilia by the Bonn-Malmö Protocol: documentation of an in vivo immunomodulating concept,” Blood, vol. 105, no. 6, pp. 2287–2293, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Lottenberg, T. B. Kentro, and C. S. Kitchens, “Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy,” Archives of Internal Medicine, vol. 147, no. 6, pp. 1077–1081, 1987. View at Google Scholar · View at Scopus